Cullinan Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BIOIMPACT CAPITAL LLC | 11/14/2025 | 7.65 M | $45.35 M | 0.00% | 12.96% |
| LYNX1 CAPITAL MANAGEMENT LP | 11/13/2025 | 5.77 M | $34.19 M | 31.02% | 9.77% |
| BVF INC/IL | 11/14/2025 | 5.75 M | $34.10 M | 0.00% | 9.74% |
| BLACKROCK, INC. | 11/12/2025 | 4.17 M | $24.73 M | -1.14% | 7.07% |
| VANGUARD GROUP INC | 11/07/2025 | 2.94 M | $17.45 M | -2.54% | 4.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2025 | 2.93 M | $17.36 M | -24.08% | 4.96% |
| BLUE OWL CAPITAL HOLDINGS LP | 11/12/2025 | 2.51 M | $14.89 M | 5.24% | 4.25% |
| KYNAM CAPITAL MANAGEMENT, LP | 11/14/2025 | 2.30 M | $13.65 M | 9.84% | 3.90% |
| CITADEL ADVISORS LLC | 11/14/2025 | 1.98 M | $11.77 M | -24.08% | 3.36% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 1.92 M | $11.41 M | 0.00% | 3.26% |
| RTW INVESTMENTS, LP | 11/14/2025 | 1.71 M | $10.12 M | 0.00% | 2.89% |
| STATE STREET CORP | 11/14/2025 | 1.68 M | $9.95 M | 4.34% | 2.84% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 1.42 M | $8.40 M | -36.45% | 2.40% |
| VR ADVISER, LLC | 11/14/2025 | 1.38 M | $8.18 M | 0.00% | 2.34% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.30 M | $7.68 M | 1.24% | 2.19% |
| SIREN, L.L.C. | 11/13/2025 | 1.19 M | $7.08 M | 0.00% | 2.02% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 1.18 M | $7.02 M | -7.26% | 2.01% |
| NEXTECH INVEST, LTD. | 11/14/2025 | 1.14 M | $6.77 M | 0.00% | 1.93% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 1.12 M | $6.65 M | 0.00% | 1.90% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 983.96 K | $5.83 M | 40.14% | 1.67% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 11/12/2025 | 595.49 K | $3.53 M | 0.00% | 1.01% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 571.74 K | $3.39 M | 0.87% | 0.97% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 557.19 K | $3.30 M | -15.74% | 0.94% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 550.47 K | $3.26 M | 7.76% | 0.93% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 529.41 K | $3.14 M | 58.26% | 0.90% |
| NORTHERN TRUST CORP | 11/14/2025 | 447.27 K | $2.65 M | -1.31% | 0.76% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 402.64 K | $2.39 M | -7.55% | 0.68% |
| MORGAN STANLEY | 11/14/2025 | 400.15 K | $2.37 M | 65.29% | 0.68% |
| JANE STREET GROUP, LLC | 11/14/2025 | 300.89 K | $1.78 M | 515.52% | 0.51% |
| MARSHALL WACE, LLP | 11/13/2025 | 295.44 K | $1.75 M | -52.85% | 0.50% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 263.82 K | $1.56 M | 0.00% | 0.45% |
| BARCLAYS PLC | 11/12/2025 | 251.11 K | $1.49 M | -6.47% | 0.43% |
| ALGERT GLOBAL LLC | 11/14/2025 | 236.09 K | $1.40 M | 9.51% | 0.40% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2025 | 222.32 K | $1.32 M | 100.00% | 0.38% |
| VOSS CAPITAL, LLC | 11/20/2025 | 221.47 K | $1.31 M | -12.02% | 0.38% |
| NUVEEN, LLC | 11/12/2025 | 215.60 K | $1.28 M | 19.32% | 0.37% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 197.92 K | $1.17 M | 846.08% | 0.34% |
| JUMP FINANCIAL, LLC | 11/13/2025 | 194.51 K | $1.15 M | 100.00% | 0.33% |
| UBS GROUP AG | 11/13/2025 | 188.19 K | $1.12 M | -39.55% | 0.32% |
| TREXQUANT INVESTMENT LP | 11/14/2025 | 187.62 K | $1.11 M | 57.21% | 0.32% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/07/2025 | 177.69 K | $1.05 M | 1,665.90% | 0.30% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 168.13 K | $997.02 K | -9.65% | 0.28% |
| XTX TOPCO LTD | 11/14/2025 | 167.98 K | $996.12 K | 289.79% | 0.28% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 152.41 K | $903.79 K | 127.07% | 0.26% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 149.93 K | $889.05 K | -3.82% | 0.25% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 141.07 K | $836.54 K | 12.68% | 0.24% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/13/2025 | 139.02 K | $824.41 K | 98.48% | 0.24% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 11/14/2025 | 124.53 K | $738.47 K | 100.00% | 0.21% |
| CITIGROUP INC | 11/10/2025 | 107.18 K | $635.55 K | 304.57% | 0.18% |
| INVESCO LTD. | 11/13/2025 | 102.31 K | $606.71 K | 68.96% | 0.17% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cullinan Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 184 institutional investors and hedge funds held shares of Cullinan Therapeutics, Inc.. The most heavily invested institutionals were:
BioImpact Capital LLC: 7.65 M
Lynx1 Capital Management LP: 5.77 M
BVF INC/IL: 5.75 M
BlackRock, Inc.: 4.17 M
VANGUARD GROUP INC: 2.94 M
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 2.93 M
103.49% of Cullinan Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 70.49 M shares in the last 24 months. This purchase volume represents approximately $415.89 M in transactions.